Highlights of the Upcoming Investor Conferences
Stereotaxis, a leading name in surgical robotics for minimally invasive endovascular interventions, is gearing up to present at two major investor conferences in New York City. Both events promise to be significant for the company as they aim to showcase their innovations and strategic vision moving forward.
Conference Details and Presentations
David Fischel, the Chairman and CEO of Stereotaxis, is set to represent the company at the upcoming H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event will take place in the vibrant atmosphere of New York City on a date that resonates with investors interested in cutting-edge medical technologies. David will provide a comprehensive overview of the company's business, highlighting the advancements in their robotic systems designed for minimally invasive surgeries.
One-on-One Meetings Available
On Wednesday, September 10, 2025, at 8:00 am EDT, Mr. Fischel will be available for one-on-one meetings with interested investors, allowing for deeper discussions about how Stereotaxis is evolving and addressing the needs of modern healthcare.
Another Key Engagement at Lake Street Capital
Following the H.C. Wainwright event, Mr. Fischel will be participating in the Lake Street Capital 9th Annual Best Ideas Growth Conference on Thursday, September 11, 2025. This conference presents another opportunity for investors to engage directly with the leadership at Stereotaxis, discussing potential developments and future directions.
Importance of These Conferences
Mr. Fischel expressed enthusiasm regarding the conferences, emphasizing, "We are excited to participate in these conferences and look forward to sharing the technological and commercial progress being made in Stereotaxis' growth strategy." The participation in these events underscores Stereotaxis’ ongoing commitment to innovation and investor relations.
About Stereotaxis
Established as a pioneer in the field, Stereotaxis (STXS) is recognized globally for its innovative surgical robotics technologies aimed at enhancing the safety and efficacy of minimally invasive procedures. Their mission encompasses not only the development of advanced robotic systems but also the commitment to improving patient care and expanding access to treatment options. The technology developed by Stereotaxis has already benefitted over 150,000 patients worldwide, establishing a solid reputation in the healthcare industry.
Fostering Innovation
The advancements in the robotic systems developed by Stereotaxis are designed to empower healthcare professionals in the operating room, enhancing productivity and ensuring precise procedures. This focus on innovation is crucial in an industry that increasingly demands improved outcomes with minimal invasiveness.
Company Leadership and Contacts
Stereotaxis is led by a dedicated team passionate about advancing healthcare technology. David L. Fischel, the Chairman and CEO, along with Kimberly Peery, the Chief Financial Officer, plays vital roles in driving the company forward.
For inquiries and further information about Stereotaxis, you can contact:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
Frequently Asked Questions
What conferences will Stereotaxis participate in?
Stereotaxis will participate in the H.C. Wainwright 27th Annual Global Investment Conference and Lake Street Capital 9th Annual Best Ideas Growth Conference.
Who is the CEO of Stereotaxis?
David Fischel serves as the Chairman and CEO of Stereotaxis.
What is the main mission of Stereotaxis?
Stereotaxis is focused on the discovery, development, and delivery of robotic systems for interventional laboratories, enhancing patient care and connectivity in the operating room.
How many patients have been treated with Stereotaxis technology?
Stereotaxis technology has been utilized in treating over 150,000 patients worldwide.
How can investors arrange one-on-one meetings with the company?
Investors can register through the conferences to arrange one-on-one meetings with Mr. Fischel.
